ArticleClinical and experimental medicine2026
Association between weekend catch-up sleep and Metabolic dysfunction-associated steatotic liver disease in US adults.
Article in Clinical and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Circadian and behavioral timing in MASLD: a systematic review of human observational studies.EClinicalMedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The present study aims to investigate the relationship between weekend catch-up sleep (WCS) and Metabolic dysfunction-associated steatotic liver disease (MASLD) in US adults aged 20 years and above. Data were obtained from the National Health and Nutrition Examination Survey (2017–2020), a total of 4803 eligible participants were included in this study. Weighted logistic regression modeling, stratified subgroup analysis, and restricted cubic splines (RCS) were employed to examine the association between WCS and MASLD. In weighted logistic regression analyses, a significant positive association was observed between WCS and MASLD risk. When modeled as a continuous variable, each 1-hour increase in WCS was associated with a 9% higher odds of MASLD (OR = 1.09, 95% CI: 1.02–1.16, P = 0.02). Similarly, binary analysis (WCS > 1 h vs. ≤1 h) showed a robust and significant association, with a 38% increase in MASLD odds in the fully adjusted model (OR = 1.38, 95% CI: 1.14–1.67, P = 0.006). The subgroup analyses revealed statistically significant positive associations were specifically observed among older adults (≥ 60 years), individuals with hypertension, and current smokers(P < 0.05), while no statistically significant interactions (all P for interaction > 0.05). A linear dose-response relationship between WCS and MASLD risk was observed in the RCS analysis(P for non-linearity = 0.222; P for overall = 0.003). Prolonged WCS was significantly associated with an elevated risk of metabolic MASLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.